Suppr超能文献

库欣病:大剂量地塞米松抑制疗法治疗一例药物治疗难治性病例

Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.

作者信息

Warren S E, Westbie D K, Daly R, Bower R H

出版信息

South Med J. 1979 Apr;72(4):412-4.

PMID:219547
Abstract

A patient with Cushing's disease failed to show complete suppressibility of adrenal function with conventional "high" doses of dexamethasone (8 mg per day). Higher doses were required to achieve suppression. Pituitary irradiation and medical therapy (cyproheptadine, metyrapone, and aminoglutethimide) failed to control the disease, necessitating bilateral adrenalectomy. The diagnostic and therapeutic implications of megadose dexamethasone suppression have not been clearly addressed in the medical literature. It is possible that adrenal suppression achieved only with unconventionally high doses of steroids may be predictive of refractoriness to nonsurgical therapy.

摘要

一名库欣病患者使用常规“高”剂量地塞米松(每日8毫克)时,肾上腺功能未表现出完全抑制。需要更高剂量才能实现抑制。垂体放疗和药物治疗(赛庚啶、甲吡酮和氨鲁米特)未能控制该病,因此需要进行双侧肾上腺切除术。医学文献中尚未明确探讨大剂量地塞米松抑制的诊断和治疗意义。仅通过非常规高剂量类固醇实现的肾上腺抑制可能预示着对非手术治疗的难治性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验